Professional Experiences

List of Publications   

Original Articles:

• Shinichiro Sunamura, Kimio Satoh, Ryo Kurosawa, Tomohiro Ohtsuki, Nobuhiro Kikuchi, Md. Elias-Al-Mamun, Toru Shimizu, Shohei Ikeda, Kota Suzuki, Taijyu Satoh, Junichi Omura, Masamichi Nogi, Kazuhiko Numano, Mohammad Abdul Hai Siddique, Satoshi Miyata, Masahito Miura, Hiroaki Shimokawa: Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and postcapillary pulmonary hypertension in mice.  Accepted and published in PNAS. (July 9), 2018. DOI: www.pnas.org/cgi/doi/10.1073/pnas.1721298115.  (Epub ahead of print)

• Masamichi Nogi, Kimio Satoh, Shinichiro Sunamura, Nobuhiro Kikuchi, Taijyu Satoh, Ryo Kurosawa, Junichi Omura, Md. Elias-Al-Mamun, Mohammad Abdul Hai Siddique, Kazuhiko Numano, Shun Kudo, Satoshi Miyata, Masatoshi Akiyama, Kiichiro Kumagai, Shunsuke Kawamoto, Yoishikatsu Saiki, Hiroaki Shimokawa: SmgGDS Prevents Thoracic Aortic Aneurysm Formation and Rupture by Phenotypic Preservation of Aortic Smooth Muscle Cells.  Accepted and published in Circulation. (June 19), 2018. DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.035648. Circulation. 2018; CIRCULATIONAHA.118.035648.  (Epub ahead of print)

• Nobuhiro Kikuchi, Kimio Satoh, Ryo Kurosawa, Nobuhiro Yaoita, Md. Elias-Al-Mamun, Mohammad Abdul Hai Siddique, Junichi Omura, Taijyu Satoh, Masamichi Nogi, Shinichiro Sunamura, Satoshi Miyata, Yoshiro Saito, Yasushi Hoshikawa, Yoshinori Okada, Hiroaki Shimokawa: Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target.  Accepted and published in Circulation. (April 10), 2018. DOI: https://doi.org/10.1161/CIRCULATIONAHA.117.033113. Circulation. 2018; CIRCULATIONAHA.117.033113.  (Epub ahead of print)

• Md. Elias-Al-Mamun, Abdullah Al Mamun (Jan, 2018): Gift as a Promotional Material and the Related Prescription Behaviour of Physicians in Bangladesh Pharmaceutical Market. World Journal of Pharmacy and Pharmaceutical Sciences. 7(1); 106-119.

• Taijyu Satoh, Kimio Satoh, Nobuhiro Yaoita, Nobuhiro Kikuchi, Junichi Omura, Ryo Kurosawa, Kazuhiko Numano, Elias Al-Mamun, Mohammad Abdul Hai Siddique, Shinichiro Sunamura, Masamichi Nogi, Kota Suzuki, Satoshi Miyata, John Morser, Hiroaki Shimokawa (April, 2017): Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.  Circ Res. 120; 1246-1262. DOI: 10.1161/CIRCRESAHA.117.310640.

• Muhammad Rashedul Islam, Shadid Uz Zaman, Md. Elias-Al-Mamun, Mohammad Aziz Ullah (Jan 2017): Prescribing Trends of Anti-Ulcerant Drugs by Generic Names in Dhaka City of Bangladesh. World Journal of Pharmaceutical Research. 6(1); 41-49.

• Muhammad Rashedul Islam, Md. Mizanur Rahman Moghal, F.M. Shah Noman Ul Bari and Elias Al Mamun (Dec 2016): Design and Development of Bi-layered Sustained Release Azithromycin Tablets. Dhaka Univ. J. Pharm. Sci. 15(2); 227-234.

• Md. Elias-Al-Mamun, Tushar Saha, Muhammad Rashedul Islam (Sep 2016): Initiation and maintenance of diseases and diagnostics database for Bangladeshi individuals.  Am. J. Pharm Health Res. 4(9); 30-42.

• Muhammad Rashedul Islam, Md. Elias-Al-Mamun, and Md. Mizanur Rahman Moghal (July 2016):  Release modification of indomethacin controlled release press coated tablets. Bangladesh Pharmaceutical Journal. 19(2); 219-225.

• Muhammad Rashedul Islam, Md. Elias-Al-Mamun, Md. Mizanur Rahman Moghal and Md. Habibur Rahman (Dec 2015): Development and evaluation of indomethacin controlled release press coated tablets. Dhaka Univ. J. Pharm. Sci. 14(2); 187-192.

• Nazia Tajrin, Md. Elias-Al-Mamun, Md. Habibur Rahman and Md. Selim Reza (June 2015): Effect of channeling agents on release kinetics of stavudine from methocel K100 LVCR and ethocel 20 cps based matrix tablets. Dhaka Univ. J. Pharm. Sci.  14(1); 91-101.

• Md. Abdullah Al Mahmud, Subrata Bhadra, Afroza Haque, Md. Elias-Al-Mamun and Syed Shabbir Haider (June 2014): Development and Validation of HPLC Method for Simultaneous Determination of Gliclazide and Enalapril Maleate in Tablet Dosage Form. Dhaka Univ. J. Pharm. Sci.  13(1); 51-56.

• Suvd Nergui, Yoshihiro Fukumoto, Zhulanqiqige Do.e, Sota Nakajima, Toru Shimizu, Shohei Ikeda, Md. Elias-Al-Mamun, and Hiroaki Shimokawa (May 2014):  Role of Endothelial Nitric Oxide Synthase and Collagen Metabolism in Right Ventricular Remodeling due to Pulmonary Hypertension.  Circ J  78(6); 1465-74.

• Md. Elias-Al-Mamun, Kimio Satoh, Shin-ichi Tanaka, Toru Shimizu, Suvd Nergui, Satoshi Miyata, Yoshihiro Fukumoto, and Hiroaki Shimokawa (April 2014):  Combination Therapy with Fasudil and Sildenafil Ameliorates Monocrotaline-Induced Pulmonary Hypertension and survival in rats.  Circ J  78(4); 967-976.

• Md. Omar Faruqe, Md. Elias-Al-Mamun and Reza-ul Jalil (June 2013): Evaluation of the Dissolution Profile of Hard Gelatin Capsule Filled with Ibuprofen Liquid. CDR J. 5(1): 11-18.

• Md. Elias-Al-Mamun, Md. Asaduzzaman, Md. Saiful Islam and Reza-ul Jalil (August 2012): Effect of Hydrophobic Excipients on Release Kinetics of Ciprofloxacin from Kollidon® SR Embedded Matrix Tablets.  Asian J Pharm Clin Res.  5(3): 51-55.

• Nahid sharmin, Md. Elias-Al-Mamun, Md. Saiful Islam, and Reza-ul Jalil (June 2011). Preparation and Characterization of Lidocaine Double Layer Buccal Tablet using Mucoadhesive Carbopol® Polymer.  Dhaka Univ. J. Pharm. Sci. 10(1): 29-34.

• Md. Elias-Al-Mamun, Afroza Haque and Syed Shabbir Haider (March 2011): Development and Evaluation of Combined Gliclazide and Enalapril Maleate Immediate Release Tablet. J. Pharm. Sci. & Res.  3(3): 1103-1109.

• Nahid sharmin, Md. Elias-Al-Mamun, Reza-ul Jalil (July 2010): A Novel Method to Study the Effect of pH and Excipients on Water Uptake and Swelling Behavior of Carbopol Polymers. Bangladesh Pharmaceutical Journal. 13(2): 1-7.

• Md. Asaduzzaman, Md. Elias-Al-Mamun, Md. Saiful Islam, Reza-ul Jalil (December 2009): Effect of HPMC 4 cps and Carbopol 974p NF on Release Kinetics of Ciprofloxacin from Kollidon® SR Embedded Matrix Tablets. J. Pharm. Sci. & Res. 1(4): 137-145.

• Md. Elias-Al-Mamun, Humaira Afreen Khan, Irin Dewan and Reza-ul Jalil (October 2009): In vitro Study on Tamsulosin Release Kinetics from Biodegradable PLGA In situ Implants. Pak. J. Pharm. Sci.  22(4): 360-367.

• Irin Dewan, Md. Elias-Al-Mamun and Reza-ul Jalil (December 2008): Studies on Swelling Behavior of HPMC based Matrix Tablets by the Application of Digital Imaging Technique. Dhaka Univ. J. Pharm. Sci. 7(2): 169-175.

• Irin Dewan, Md. Elias-Al-Mamun and Reza-ul Jalil (December 2007): In vitro Release Kinetics of Progesterone from Biodegradable In situ Implant System. Dhaka Univ. J. Pharm. Sci. 6(2): 99-103.

• M Elias-Al-Mamun, M Hazrat Ali, Monira Ahsan, Nazmul Qais and Rasheduzzaman Chowdhury (June 2004): In vitro Antibacterial Activity of the Crude Extracts of Hedyotis corymbosa and Elaeocarpus robustus. Bangladesh J  Microbiol. 21(1): 42-43.

 List of Abstracts at Scientific Sessions/Meetings: 

• Md. Elias Al-Mamun, Kimio Satoh, Taijyu Satoh, Nobuhiro Yaoita, Mohammad Abdul Hai Siddique, Nobuhiro Kikuchi, Junichi Omura, Ryo Kurosawa, Shinichiro Sunamura, Masamichi Nogi, Tomohiro Otsuki, Hiroaki Shimokawa (2017): Rivaroxaban Prevents the Development of Chronic Thromboembolic Pulmonary Hypertension in Mice- Novel Beneficial Effects of the FXa Inhibitor. e-Poster presented at Moderated Poster Session (presentation number P4926) at scientific congress by European Society of Cardiology (ESC) in Fira Gran Via, Barcelona, Spain; August 26-30.

• Masamichi Nogi, Kimio Satoh, Shun Kudo, Junichi Omura, Nobuhiro Kikuchi, Taijyu Satoh, Shinichiro Sunamura, Ryo Kurosawa, Md. Elias Al-Mamun, Mohammad Abdul Hai Siddique, Tomohiro Otsuki, Hiroaki Shimokawa (2017): Protective Roles of small GTP-binding Protein GDP Dissociation Stimulator Against Angiotensin II-induced Thoracic Aortic Aneurysm Formation and Rupture in Mice- A Possible Novel Therapeutic Target. e-Poster presented at Best Poster in Atherosclerosis Session (presentation number P5164) at scientific congress by European Society of Cardiology (ESC) in Fira Gran Via, Barcelona, Spain; August 26-30.

• Taijyu Satoh, Kimio Satoh, Nobuhiro Yaoita, Md. Elias Al-Mamun, Mohammad Abdul Hai Siddique, Nobuhiro Kikuchi, Junichi Omura, Ryo Kurosawa, Shinichiro Sunamura, Masamichi Nogi, Tomohiro Otsuki, Satoshi Miyata, Hiroaki Shimokawa (2017): Thrombin Activatable Fibrinolysis Inhibitor Promotes Development of Chronic Thromboembolic Pulmonary Hypertension-A Possible Novel Therapeutic Target. Young Investigator Award Session Basic Science Finalist Lecture ( presentation number 1983) presented at scientific congress by European Society of Cardiology (ESC) in Fira Gran Via, Barcelona, Spain; August 26-30.

• Mohammad Abdul Hai Siddique, Kimio Satoh, Ryo Kurosawa, Md. Elias Al-Mamun, Nobuhiro Kikuchi, Junichi Omura, Taijyu Satoh, Masamichi Nogi, Shinichiro Sunamura, Hiroaki Shimokawa (2017): Identification of Emetine as a Novel Therapeutic Agent for Pulmonary Hypertension in Rats -High-throughput Screening of 5,562 Compounds. Accepted for oral presentation during the Young Investigator’s Award for International Students Finalists Lecture at the 81st  Annual Scientific Meeting of Japanese Circulation Society in Kanazawa, Japan; March 17-19.

• Mohammad Abdul Hai Siddique, Kimio Satoh, Ryo Kurosawa, Md. Elias Al-Mamun, Nobuhiro Kikuchi, Junichi Omura, Taijyu Satoh, Masamichi Nogi, Shinichiro Sunamura, Hiroaki Shimokawa (2016): Identification of Emetine as a Novel Therapeutic Agent for Pulmonary Hypertension in Rats -High-throughput Screening of 5,562 Compounds. Poster (Number: T4238, category: 14.72) presented at Scientific sessions by American Heart Association (AHA) in New Orleans, Louisiana, USA; November 12-16.

• Taijyu Satoh, Kimio Satoh, Nobuhiro Yaoita, Nobuhiro Kikuchi, Junichi Omura, Ryo Kurosawa,  Shinichiro Sunamura, Masamichi Nogi, Tomohiro Otsuki, Kazuhiko Numano, Md. Elias Al-Mamun, Mohammad Abdul Hai Siddique, Shunsuke Tatabe, Tatsu Aoki, Hiroaki Shimokawa (2016): Thrombin Activatable Fibrinolysis Inhibitor Promotes Development of Chronic Thromboembolic Pulmonary Hypertension-A Possible Novel Therapeutic Target. Abstract Rapid Fire oral (Latest in CTEPH and RV Dysfunction Session, category: 14.72) presented at Scientific sessions by American Heart Association (AHA) in New Orleans, Louisiana, USA; November 12-16.

• Ryo Kurosawa, Kimio Satoh, Nobuhiro Kikuchi, Junichi Omura, Taijyu Satoh, Masamichi Nogi, Shinichiro Sunamura, Kazuhiko Numano, Kota Suzuki, Mohammad Abdul Hai Siddique, Elias Al-Mamun, Hiroaki Shimokawa (2016): Celastramycin Inhibits Pulmonary Arterial Smooth Muscle Cell Proliferation and Ameliorates Hypoxia-induced Pulmonary Hypertension in Mice. Poster (Number: T5266, category: 14.72) presented at Scientific sessions by American Heart Association (AHA) in New Orleans, Louisiana, USA; November 12-16.

• Ryo Kurosawa, Kimio Satoh, Nobuhiro Kikuchi, Junichi Omura, Taijyu Sato, Masamichi Nogi, Numano Kazuhiko, Mohammad Abdul Hai Siddique, Md. Elias Al-Mamun, Syunsuke Tatebe, Tatsui Aoki, Koichiro Sugimura, Hiroaki Shimokawa (2016): Development of new therapeutic agent for pulmonary hypertension by compound screening. Japanese pulmonary hypertension, pulmonary circulation society (JPHCS) 1st scientific meeting; Tokyo, Japan, OR5-5(Fundamentals of pulmonary hypertension, pulmonary circulation) (Oct 1-2).

• Taijyu Satoh, Kimio Satoh, Nobuhiro Yaoita, Nobuhiro Kikuchi, Junichi Omura, Ryo Kurosawa,  Elias Al-Mamun, Mohammad Abdul Hai Siddique, Shinichiro Sunamura, Hiroaki Shimokawa (2016): Involvement of TAFI is a new mechanism for the pathogenesis of chronic thromboembolic pulmonary hypertension. Japanese pulmonary hypertension, pulmonary circulation society (JPHCS) 1st scientific meeting; Tokyo, Japan, OR5-9 (Fundamentals of pulmonary hypertension, pulmonary circulation) (Oct 1-2).

• Ryo Kurosawa, Kimio Satoh, Nobuhiro Kikuchi, Junichi Omura, Taijyu Sato, Masamichi Nogi, Numano Kazuhiko, Mohammad Siddique, Elias Al-Mamun, Koichiro Sugimura, Hiroaki Shimokawa (2015): Development of new therapeutic agent for pulmonary hypertension by compound screening. Japanese pulmonary circulation society 4th scientific meeting; Tokyo, OR2-3(PAH1) (Oct 3-4).

• Md. Elias-Al-Mamun, Kimio Satoh, Shin-ichi Tanaka, Toru Shimizu, Suvd Nergui, Satoshi Miyata, Yoshihiro Fukumoto and Hiroaki Shimokawa (2015):   Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension through synergistic inhibition of Rho-kinase.  Accepted for oral presentation during the Young Investigator’s Award for International Students Finalists Lecture at the 79th Annual Scientific Meeting of Japanese Circulation Society in Osaka; April 24-26.

• Md. Elias-Al-Mamun, Kimio Satoh, Shin-ichi Tanaka, Toru Shimizu, Suvd Nergui, Satoshi Miyata, Yoshihiro Fukumoto and Hiroaki Shimokawa (2014):   Combination Therapy with Fasudil and Sildenafil Exerts Synergistic Effects Through Inhibition of Rho-kinase in Pulmonary Hypertension.  Accepted for poster presentation at the 78th Annual Scientific Meeting of Japanese Circulation Society in Tokyo; March 21-23.

• Suvd Nergui, Yoshihiro Fukumoto, Zhulanqiqige Do.e, Md. Elias-Al-Mamun, Hiroaki Shimokawa (2013):  Molecular and cellular mechanisms of right ventricular remodeling in pulmonary hypertension.  Poster (Number: 11935) presented at Scientific sessions by American Heart Association (AHA) in Dallas, TX, USA; November 16̴20.

• Md. Elias-Al-Mamun, Kimio Satoh, Shin-ichi Tanaka, Toru Shimizu, Suvd Nergui, Yoshihiro Fukumoto and Hiroaki Shimokawa (2013). Combination Therapy with Fasudil and Sildenafil Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats. Circ J. 77 (Suppl I): PE-415; 1766

• Suvd Nergui, Yoshihiro Fukumoto, Zhulanqiqige Do.e, Md. Elias-Al-Mamun, Hiroaki Shimokawa (2013):  Impact of endothelial nitric oxide synthase on the development of right ventricular dysfunction caused by pulmonary hypertension.  Circ J. 77 (Suppl I): PE-413; 1764.

• Md. Elias-Al-Mamun, Kimio Satoh, Shin-ichi Tanaka, Toru Shimizu, Suvd Nergui, Yoshihiro Fukumoto and Hiroaki Shimokawa (2013). Combination Therapy with Fasudil and Sildenafil Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats. Japanese pulmonary circulation society 2^nd scientific meeting. O-25.

• Suvd Nergui, Yoshihiro Fukumoto, Zhulanqiqige Do.e, Md. Elias-Al-Mamun, Hiroaki Shimokawa (2013):  Impact of endothelial nitric oxide synthase on the development of right ventricular dysfunction caused by pulmonary hypertension.  Japanese pulmonary circulation society 2nd scientific meeting; Tokyo, O-22.

Oral Presentations:

• Taijyu Satoh, Kimio Satoh, Nobuhiro Yaoita, Md. Elias Al-Mamun, Mohammad Abdul Hai Siddique, Nobuhiro Kikuchi, Junichi Omura, Ryo Kurosawa, Shinichiro Sunamura, Masamichi Nogi, Tomohiro Otsuki, Satoshi Miyata, Hiroaki Shimokawa (2017): Thrombin Activatable Fibrinolysis Inhibitor Promotes Development of Chronic Thromboembolic Pulmonary Hypertension-A Possible Novel Therapeutic Target. Young Investigator Award Session Basic Science Finalist Lecture ( presentation number 1983) presented at scientific congress by European Society of Cardiology (ESC) in Fira Gran Via, Barcelona, Spain; August 26-30.

• Mohammad Abdul Hai Siddique, Kimio Satoh, Ryo Kurosawa, Md. Elias Al-Mamun, Nobuhiro Kikuchi, Junichi Omura, Taijyu Satoh, Masamichi Nogi, Shinichiro Sunamura, Hiroaki Shimokawa (2017): Identification of Emetine as a Novel Therapeutic Agent for Pulmonary Hypertension in Rats -High-throughput Screening of 5,562 Compounds. Accepted for oral presentation during the Young Investigator’s Award for International Students Finalists Lecture at the 81st  Annual Scientific Meeting of Japanese Circulation Society in Kanazawa, Japan; March 17-19.

• Taijyu Satoh, Kimio Satoh, Nobuhiro Yaoita, Nobuhiro Kikuchi, Junichi Omura, Ryo Kurosawa,  Shinichiro Sunamura, Masamichi Nogi, Tomohiro Otsuki, Kazuhiko Numano, Md. Elias Al-Mamun, Mohammad Abdul Hai Siddique, Shunsuke Tatabe, Tatsu Aoki, Hiroaki Shimokawa (2016): Thrombin Activatable Fibrinolysis Inhibitor Promotes Development of Chronic Thromboembolic Pulmonary Hypertension-A Possible Novel Therapeutic Target. Abstract Rapid Fire oral (Latest in CTEPH and RV Dysfunction Session, category: 14.72) presented at Scientific sessions by American Heart Association (AHA) in New Orleans, Louisiana, USA; November 12-16.

• Ryo Kurosawa, Kimio Satoh, Nobuhiro Kikuchi, Junichi Omura, Taijyu Sato, Masamichi Nogi, Numano Kazuhiko, Mohammad Abdul Hai Siddique, Md. Elias Al-Mamun, Syunsuke Tatebe, Tatsui Aoki, Koichiro Sugimura, Hiroaki Shimokawa (2016): Development of new therapeutic agent for pulmonary hypertension by compound screening. Japanese pulmonary hypertension, pulmonary circulation society (JPHCS) 1st scientific meeting; Tokyo, Japan, OR5-5(Fundamentals of pulmonary hypertension, pulmonary circulation) (Oct 1-2).

• Taijyu Satoh, Kimio Satoh, Nobuhiro Yaoita, Nobuhiro Kikuchi, Junichi Omura, Ryo Kurosawa,  Elias Al-Mamun, Mohammad Abdul Hai Siddique, Shinichiro Sunamura, Hiroaki Shimokawa (2016): Involvement of TAFI is a new mechanism for the pathogenesis of chronic thromboembolic pulmonary hypertension. Japanese pulmonary hypertension, pulmonary circulation society (JPHCS) 1st scientific meeting; Tokyo, Japan, OR5-9 (Fundamentals of pulmonary hypertension, pulmonary circulation) (Oct 1-2).

• Ryo Kurosawa, Kimio Satoh, Nobuhiro Kikuchi, Junichi Omura, Taijyu Sato, Masamichi Nogi, Numano Kazuhiko, Mohammad Siddique, Elias Al-Mamun, Koichiro Sugimura, Hiroaki Shimokawa (2015): Development of new therapeutic agent for pulmonary hypertension by compound screening. Japanese pulmonary circulation society 4th scientific meeting; Tokyo, OR2-3(PAH1) (Oct 3-4).

• Md. Elias-Al-Mamun, Kimio Satoh, Shin-ichi Tanaka, Toru Shimizu, Suvd Nergui, Satoshi Miyata, Yoshihiro Fukumoto and Hiroaki Shimokawa (2015):   Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension through synergistic inhibition of Rho-kinase.  Accepted for oral presentation during the Young Investigator’s Award for International Students Finalists Lecture at the 79th Annual Scientific Meeting of Japanese Circulation Society in Osaka; April 24-26.

• Md. Elias-Al-Mamun, Kimio Satoh, Shin-ichi Tanaka, Toru Shimizu, Suvd Nergui, Yoshihiro Fukumoto and Hiroaki Shimokawa (2013). Combination Therapy with Fasudil and Sildenafil Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats. Japanese pulmonary circulation society 2^nd scientific meeting. O-25.

• Suvd Nergui, Yoshihiro Fukumoto, Zhulanqiqige Do.e, Md. Elias-Al-Mamun, Hiroaki Shimokawa (2013):  Impact of endothelial nitric oxide synthase on the development of right ventricular dysfunction caused by pulmonary hypertension.  Japanese pulmonary circulation society 2nd scientific meeting; Tokyo, O-22.

Poster Presentations:

• Md. Elias Al-Mamun, Kimio Satoh, Taijyu Satoh, Nobuhiro Yaoita, Mohammad Abdul Hai Siddique, Nobuhiro Kikuchi, Junichi Omura, Ryo Kurosawa, Shinichiro Sunamura, Masamichi Nogi, Tomohiro Otsuki, Hiroaki Shimokawa (2017): Rivaroxaban Prevents the Development of Chronic Thromboembolic Pulmonary Hypertension in Mice- Novel Beneficial Effects of the FXa Inhibitor. e-Poster presented at Moderated Poster Session (presentation number P4926) at scientific congress by European Society of Cardiology (ESC) in Fira Gran Via, Barcelona, Spain; August 26-30.

• Masamichi Nogi, Kimio Satoh, Shun Kudo, Junichi Omura, Nobuhiro Kikuchi, Taijyu Satoh, Shinichiro Sunamura, Ryo Kurosawa, Md. Elias Al-Mamun, Mohammad Abdul Hai Siddique, Tomohiro Otsuki, Hiroaki Shimokawa (2017): Protective Roles of small GTP-binding Protein GDP Dissociation Stimulator Against Angiotensin II-induced Thoracic Aortic Aneurysm Formation and Rupture in Mice- A Possible Novel Therapeutic Target. e-Poster presented at Best Poster in Atherosclerosis Session (presentation number P5164) at scientific congress by European Society of Cardiology (ESC) in Fira Gran Via, Barcelona, Spain; August 26-30.

• Mohammad Abdul Hai Siddique, Kimio Satoh, Ryo Kurosawa, Md. Elias Al-Mamun, Nobuhiro Kikuchi, Junichi Omura, Taijyu Satoh, Masamichi Nogi, Shinichiro Sunamura, Hiroaki Shimokawa (2016): Identification of Emetine as a Novel Therapeutic Agent for Pulmonary Hypertension in Rats -High-throughput Screening of 5,562 Compounds. Poster (Number: T4238, category: 14.72) presented at Scientific sessions by American Heart Association (AHA) in New Orleans, Louisiana, USA; November 12-16.

• Ryo Kurosawa, Kimio Satoh, Nobuhiro Kikuchi, Junichi Omura, Taijyu Satoh, Masamichi Nogi, Shinichiro Sunamura, Kazuhiko Numano, Kota Suzuki, Mohammad Abdul Hai Siddique, Elias Al-Mamun, Hiroaki Shimokawa (2016): Celastramycin Inhibits Pulmonary Arterial Smooth Muscle Cell Proliferation and Ameliorates Hypoxia-induced Pulmonary Hypertension in Mice. Poster (Number: T5266, category: 14.72) presented at Scientific sessions by American Heart Association (AHA) in New Orleans, Louisiana, USA; November 12-16.

• Md. Elias-Al-Mamun, Kimio Satoh, Shin-ichi Tanaka, Toru Shimizu, Suvd Nergui, Satoshi Miyata, Yoshihiro Fukumoto and Hiroaki Shimokawa (2014):   Combination Therapy with Fasudil and Sildenafil Exerts Synergistic Effects Through Inhibition of Rho-kinase in Pulmonary Hypertension.  Accepted for poster presentation at the 78th Annual Scientific Meeting of Japanese Circulation Society in Tokyo; March 21-23.

• Suvd Nergui, Yoshihiro Fukumoto, Zhulanqiqige Do.e, Md. Elias-Al-Mamun, Hiroaki Shimokawa (2013):  Molecular and cellular mechanisms of right ventricular remodeling in pulmonary hypertension.  Poster (Number: 11935) presented at Scientific sessions by American Heart Association (AHA) in Dallas, TX, USA; November 16̴20

• Md. Elias-Al-Mamun, Kimio Satoh, Shin-ichi Tanaka, Toru Shimizu, Suvd Nergui, Yoshihiro Fukumoto and Hiroaki Shimokawa (2013). Combination Therapy with Fasudil and Sildenafil Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats. Circ J. 77 (Suppl I): PE-415; 1766

• Suvd Nergui, Yoshihiro Fukumoto, Zhulanqiqige Do.e, Md. Elias-Al-Mamun, Hiroaki Shimokawa (2013):  Impact of endothelial nitric oxide synthase on the development of right ventricular dysfunction caused by pulmonary hypertension.  Circ J. 77 (Suppl I): PE-413; 1764.

Conference / Training Attended

Professional Memberships

• Member of Bangladesh Pharmacy Council (BPC) License No: A-2231
• Pharmacy Graduates' Association (PGA), Bangladesh
• Bangladesh Pharmaceutical Society (BPS)
• Dhaka University Pharmaceutical Society (DUPS)
• BCS Administrative Service Association (ID No-15518)
• Member of Japanese Circulation Society (JCS) (No: 139570)

Awards Received

•  2017: Junior Investigator Travel Award by American Heart Association (AHA) at Anaheim, California, USA on November 14, 2017.
• 2014-2018: JSPS Postdoctoral Fellowship for Foreign Researchers (Pathway to University Positions in Japan) at Tohoku University in Japan (November 22, 2014 to December 31, 2014; and March 1, 2016 to January 22, 2018).
• 2015: Young Investigator’s Award for International Students by Japanese Circulation Society at Osaka, Japan on April 24-26, 2015.
• 2009-2014:  Japanese Government (MONBUKAGAKUSHO: MEXT) Scholarship for PhD Study at Tohoku University in Japan (From October 2009 to March 2014).
• 2000: University Merit Scholarship for achieving First Class First position in M. Pharm (2000) examination at Dhaka University.
• 1999: University Merit Scholarship for achieving First Class Second position in B. Pharm (1999) examination at Dhaka University.
• 1995-1999: Board Scholarship by Ministry of Education, Bangladesh for getting better marks in Higher Secondary School Certificate (H.S.C.) examination 1994.
• 1992-1994: Board Scholarship by Ministry of Education, Bangladesh for getting better marks in Secondary School Certificate (S.S.C.) examination 1992.
• 1990-1991:  Govt. Scholarship by Ministry of Education, Bangladesh Scholarship in junior school held in the eighth year of schooling’ 1989.
• 1987-1989:  Govt. Scholarship by Ministry of Education, Bangladesh Scholarship in primary school held in the fifth year of schooling’ 1986.

Research Experience:

• Post-Doctoral Research (Under JSPS Fellowship, JAPAN) - Dept. of Cardiovascular Medicine, Tohoku University, Japan; Nov 2014-Dec 2014; Mar 2016-Jan 2018 (Supervisor: Prof. Hiroaki Shimokawa, MD, PhD)
• Development of pulmonary hypertension or right ventricular failure in animal model
• Investigation of drug efficacy on monocrotaline-induced and sugen-hypoxic pulmonary hypertension in rats
• Development of pulmonary hypertension using hypoxia with genetically modified mice.
• Management of mice including breeding, mating and producing genetically modified mice.
• Analysis of different methods used in pulmonary hypertension model including hemodynamics, histology analysis, western blotting, echocardiography and survival.
• In vitro study with different cells including HPASMC, HPAEC or primary cell culture etc.

• Doctoral Research (Under MEXT Scholarship, JAPAN) - Dept. of Cardiovascular Medicine, Tohoku University, Japan; 2009-2014 (Supervisor: Prof. Hiroaki Shimokawa, MD, PhD)
  • Development of pulmonary hypertension or right ventricular failure in animal model
  • Investigation of drug efficacy on monocrotaline-induced pulmonary hypertension in rats
  • Analysis of different methods used in pulmonary hypertension model including hemodynamics, histology analysis, western blotting, echocardiography and survival.

• As a supervisor / co-supervisor of Master’s Research Student - Dept. of Pharmaceutical Technology, University of Dhaka, Bangladesh; 2006-2009 (Supervisor: Prof. Dr. Reza-ul Jalil)
  • Formulation and development of sustained release tablets of ciprofloxacin
  • Development and Evaluation of Combined Gliclazide and Enalapril Maleate Immediate Release Tablet
  • Preparation and Characterization of Lidocaine Double Layer Buccal Tablet
  • Investigation of in vitro drug release kinetics from this tablet
  • Research on pharmaceutical marketing

• Graduate / Master’s Research - Dept. of Pharmaceutical Technology, University of Dhaka, Bangladesh; 2003-2004 (Supervisor: Prof. Dr. Reza-ul Jalil)
  • Formulation and development of biodegradable in situ implants
  • Investigation of in vitro drug release kinetics from this implant
  • Analysis of dissolution behavior and kinetics

• Undergraduate / Honors Research - Dept. of Pharmacy, University of Dhaka, Bangladesh; 2000-2002 (Supervisor: Dr. Monira Ahsan)
  • Extraction of crude material from plant
  • Phytochemical investigation on crude extracts from Hedyotis corymbosa
  • Biological investigation on crude extracts from Hedyotis corymbosa

Research Interest

• Cardiovascular Molecular Biology (Pulmonary hypertension)
• Drug Delivery System such as Sustained Release technology, Implantation technology, Nanotechnology, Lipid drug delivery, Bioavailability enhancing technology, Combination dosage form.
• Pharmaceutical marketing and Public health related research/activities
• Molecular-based formulation of solid-state pharmaceutics
• Natural Product chemistry or phytochemical work.

Conference / Training Attended

Professional Memberships

• Member of Bangladesh Pharmacy Council (BPC) License No: A-2231
• Pharmacy Graduates' Association (PGA), Bangladesh
• Bangladesh Pharmaceutical Society (BPS)
• Dhaka University Pharmaceutical Society (DUPS)
• BCS Administrative Service Association (ID No-15518)
• Member of Japanese Circulation Society (JCS) (No: 139570)